General
Preferred name
PIRBUTEROL
Synonyms
CP-24314-1 ()
Pirbuterol HCl ()
Pyrbuterol HCl ()
PIRBUTEROL HYDROCHLORIDE ()
PIRBUTEROL ACETATE ()
ARA-211 ()
CP-24,314-14 ()
Pirbuterol monoacetate ()
Spirolair ()
CP-24314-14 ()
Maxair ()
Pyrbuterol hydrochloride ()
Pirbuterol dihydrochloride ()
NSC-355078 ()
Exirel ()
Broncocor ()
CP-24,314-1 ()
P&D ID
PD009921
CAS
38677-81-5
65652-44-0
79645-08-2
38029-10-6
100415-23-4
Tags
available
drug
Approved by
FDA
First approval
1986
Drug Status
approved
Drug indication
Bronchodilator
Asthma
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
HALF-LIFE
2 hours.
DESCRIPTION
Pirbuterol acetate is a short-acting β2 adrenoreceptor agonist. It has bronchodilating action and is used as a bronchodilator. It is also used in the treatment of asthma as a breath-activated metered-dose inhaler. It was developed by Valeant and has been listed.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
NPC Screening Collection
Other bioactive compounds
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
62
Molecular Weight
240.15
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
4
Rotatable Bonds
4
Ring Count
1
Aromatic Ring Count
1
cLogP
0.7
TPSA
85.61
Fraction CSP3
0.58
Chiral centers
1.0
Largest ring
6.0
QED
0.62
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Therapeutic Class
Bronchodilator Agents
Solubility
DMSO (Slightly), Methanol (Slightly)
Source data
